Beaudart, C; Mccloskey, E; Bruyère, O; Cesari, M; Rolland, Y; Rizzoli, R; Araujo de Carvalho, I; Amuthavalli Thiyagarajan, J; Bautmans, I; Bertière, MC; Brandi, ML; Al-Daghri, NM; Burlet, N; Cavalier, E; Cerreta, F; Cherubini, A; Fielding, R; Gielen, E; Landi, F; Petermans, J; Reginster, JY; Visser, M; Kanis, J; Cooper, C; ,
Sarcopenia is increasingly recognized as a correlate of ageing and is associated with increased likelihood of adverse outcomes including falls, fractures, frailty and mortality. Several tools have been recommended to assess muscle mass, muscle strength and physical performance in clinical trials. Whilst these tools have proven to be accurate and reliable in investigational settings, many are not easily applied to daily practice.